---
title: 'Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications'
date: '2025-01-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39775969/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20250109170927&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'PURPOSE OF REVIEW: More than a decade following the discovery of Calreticulin
  (CALR) mutations as drivers of myeloproliferative neoplasms (MPN), advances in the
  understanding of CALR-mutant MPN continue to emerge. Here, we summarize recent advances
  in mehanistic understanding and in targeted therapies for CALR-mutant ...'
disable_comments: true
---
PURPOSE OF REVIEW: More than a decade following the discovery of Calreticulin (CALR) mutations as drivers of myeloproliferative neoplasms (MPN), advances in the understanding of CALR-mutant MPN continue to emerge. Here, we summarize recent advances in mehanistic understanding and in targeted therapies for CALR-mutant ...